Definitive Contract 75N93024C00072
Award Date
9/16/24
Potential Completion Date
9/15/29
Potential Value
$7M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Nashville, TN 37232, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
18
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,244,250.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services, to Vanderbilt University Medical Center (VUMC) to conduct research on B-cell epitope discovery and mechanisms of antibody protection. The contract has no set-aside designation. VUMC has subcontracted portions of the work to Beth Israel Deaconess Medical Center, the University of North Carolina at Chapel Hill, and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Vanderbilt University Medical Center (VUMC), a nonprofit academic medical center in Nashville, Tennessee. The $109,651.01 delivery order is for VUMC's participation in the Vaccine and Treatment Evaluation Units (VTEU) program, a major NIAID initiative to conduct clinical research on vaccines and treatments for infectious diseases....
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Vanderbilt University Medical Center (VUMC). The $311,434.95 award is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) master contract, which supports clinical trials and research for vaccines and treatments. The award does not have a set-aside designation. VUMC, a nonprofit academic medical center, has extensive...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Vanderbilt University Medical Center (VUMC) as a prime contractor. The $88,002.42 firm-fixed price Delivery Order is part of the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract and supports VUMC's overall administration, clinical operations, and development/implementation of concepts and...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,659,624.64 definitive cost-no-fee contract to The Vanderbilt University for a Large Scale Antibody and T Cell Epitope Discovery Program. The contract, which does not have a set-aside designation, was awarded on September 30, 2004 with a completion date of November 29, 2009. The Vanderbilt University is a top-ranked private research...
This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Vanderbilt University Medical Center (VUMC). The contract is a Delivery Order issued under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract, with a ceiling value of $113,466.31 and a period of performance from September 15, 2015 to September 14, 2016. The contract is for task area D, sub-studies for...
This is a federal contract award from the Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases to Vanderbilt University Medical Center (VUMC), a non-profit healthcare provider, under the Vaccine and Treatment Evaluation Units (VTEU) program. The $2,052.52 contract is a delivery order for re-obligating fiscal year 2015 funds for Task Order 13-0090.B1C1D1.0014, Task B Base. The contract has a completion date of...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $26,339,000.67 definitive cost-no-fee contract to Vanderbilt University in Nashville, Tennessee, for the "Evaluation of Control Measures Against Diseases Other Than AIDS." This contract, which does not have a set-aside designation, was awarded on June 15, 2002, with a performance period through March 8, 2008. Vanderbilt University is a leading private...
This is a $1,018,872.05 delivery order awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Vanderbilt University Medical Center (VUMC) as the prime contractor. The order is part of the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle, a major program focused on vaccine and treatment development. The order provides funding to continue performance of services previously awarded under a...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Vanderbilt University Medical Center (VUMC) for the Vaccine and Treatment Evaluation Units (VTEU) Protocol Development and Implementation Task Area B-C Population Pharmacokinetic Analyses. The $929,736.13 cost-reimbursement contract does not have a set-aside designation. It is a task order issued under VUMC's existing VTEU master...